Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Electrospray ionization mass spectrometry for the hydrolysis complexes of cisplatin: implications for the hydrolysis process of platinum complexes

View through CrossRef
Non‐enzyme‐dependent hydrolysis of the drug cisplatin is important for its mode of action and toxicity. However, up until today, the hydrolysis process of cisplatin is still not completely understood. In the present study, the hydrolysis of cisplatin in an aqueous solution was systematically investigated by using electrospray ionization mass spectrometry coupled to liquid chromatography. A variety of previously unreported hydrolysis complexes corresponding to monomeric, dimeric and trimeric species were detected and identified. The characteristics of the Pt‐containing complexes were investigated by using collision‐induced dissociation (CID). The hydrolysis complexes demonstrate distinctive and correlative CID characteristics, which provides tools for an informative identification. The most frequently observed dissociation mechanism was sequential loss of NH3, H2O and HCl. Loss of the Pt atom was observed as the final step during the CID process. The formation mechanisms of the observed complexes were explored and experimentally examined. The strongly bound dimeric species, which existed in solution, are assumed to be formed from the clustering of the parent compound and its monohydrated or dihydrated complexes. The role of the electrospray process in the formation of some of the observed ions was also evaluated, and the electrospray ionization‐related cold clusters were identified. The previously reported hydrolysis equilibria were tested and subsequently refined via a hydrolysis study resulting in a renewed mechanistic equilibrium system of cisplatin as proposed from our results. Copyright © 2017 John Wiley & Sons, Ltd.
Title: Electrospray ionization mass spectrometry for the hydrolysis complexes of cisplatin: implications for the hydrolysis process of platinum complexes
Description:
Non‐enzyme‐dependent hydrolysis of the drug cisplatin is important for its mode of action and toxicity.
However, up until today, the hydrolysis process of cisplatin is still not completely understood.
In the present study, the hydrolysis of cisplatin in an aqueous solution was systematically investigated by using electrospray ionization mass spectrometry coupled to liquid chromatography.
A variety of previously unreported hydrolysis complexes corresponding to monomeric, dimeric and trimeric species were detected and identified.
The characteristics of the Pt‐containing complexes were investigated by using collision‐induced dissociation (CID).
The hydrolysis complexes demonstrate distinctive and correlative CID characteristics, which provides tools for an informative identification.
The most frequently observed dissociation mechanism was sequential loss of NH3, H2O and HCl.
Loss of the Pt atom was observed as the final step during the CID process.
The formation mechanisms of the observed complexes were explored and experimentally examined.
The strongly bound dimeric species, which existed in solution, are assumed to be formed from the clustering of the parent compound and its monohydrated or dihydrated complexes.
The role of the electrospray process in the formation of some of the observed ions was also evaluated, and the electrospray ionization‐related cold clusters were identified.
The previously reported hydrolysis equilibria were tested and subsequently refined via a hydrolysis study resulting in a renewed mechanistic equilibrium system of cisplatin as proposed from our results.
Copyright © 2017 John Wiley & Sons, Ltd.

Related Results

Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract Cisplatin is the most commonly employed chemotherapeutic drug for ovarian cancer treatment. However, most ovarian cancer patients experience recurrent cispl...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
Mass spectrometry of oligosaccharides
Mass spectrometry of oligosaccharides
Abstract I. Introduction 162  II. CHARACTERISTICS OF TANDEM MASS SPECTRA OF CARBOHYDRATES 163 A.  Ionization of Carbohydrates 163     1.  Electrospray Ionization (E...
Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry
Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry
AbstractThe platinum‐based anticancer drug cisplatin and its analog carboplatin are the most used chemotherapeutic agents worldwide. It is estimated that approximately half of all ...
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract Cisplatin has been mainly used for lung-cancer. However, cisplatin has many side effects, so the usage of cisplatin has a limitation. Recently, autophagy ha...

Back to Top